138 related articles for article (PubMed ID: 9433479)
21. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
[TBL] [Abstract][Full Text] [Related]
22. cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
Shan L; He M; Yu M; Qiu C; Lee NH; Liu ET; Snyderwine EG
Carcinogenesis; 2002 Oct; 23(10):1561-8. PubMed ID: 12376462
[TBL] [Abstract][Full Text] [Related]
23. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats.
Nakatsugi S; Ohta T; Kawamori T; Mutoh M; Tanigawa T; Watanabe K; Sugie S; Sugimura T; Wakabayashi K
Jpn J Cancer Res; 2000 Sep; 91(9):886-92. PubMed ID: 11011115
[TBL] [Abstract][Full Text] [Related]
25. Contrasting incidence of ras mutations in rat mammary and mouse skin tumors induced by anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide.
Ronai ZA; Gradia S; el-Bayoumy K; Amin S; Hecht SS
Carcinogenesis; 1994 Oct; 15(10):2113-6. PubMed ID: 7955041
[TBL] [Abstract][Full Text] [Related]
26. Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats.
Ronai Z; Lau YY; Cohen LA
Mol Carcinog; 1991; 4(2):120-8. PubMed ID: 2043252
[TBL] [Abstract][Full Text] [Related]
27. Studies on mammary carcinogenesis induced by a heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in mice and rats.
Nagao M; Ushijima T; Watanabe N; Okochi E; Ochiai M; Nakagama H; Sugimura T
Environ Mol Mutagen; 2002; 39(2-3):158-64. PubMed ID: 11921184
[TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats.
Hirose M; Nishikawa A; Shibutani M; Imai T; Shirai T
Environ Mol Mutagen; 2002; 39(2-3):271-8. PubMed ID: 11921198
[TBL] [Abstract][Full Text] [Related]
29. Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Snyderwine EG; Venugopal M; Yu M
Mutat Res; 2002 Sep; 506-507():145-52. PubMed ID: 12351154
[TBL] [Abstract][Full Text] [Related]
30. Role of DNA repair in carcinogen-induced ras mutation.
Engelbergs J; Thomale J; Rajewsky MF
Mutat Res; 2000 May; 450(1-2):139-53. PubMed ID: 10838139
[TBL] [Abstract][Full Text] [Related]
31. A cytogenetic footprint for mammary carcinomas induced by PhIP in rats.
Christian AT
Toxicology; 2002 Dec; 181-182():95-7. PubMed ID: 12505291
[TBL] [Abstract][Full Text] [Related]
32. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
33. Lack of inhibitory effect of benzyl isothiocyanate on 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in rats.
Ino N; Sugie S; Ohnishi M; Mori H
J Toxicol Sci; 1996 Aug; 21(3):189-94. PubMed ID: 8887887
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations.
El-Sohemy A; Archer MC
Carcinogenesis; 2000 Apr; 21(4):827-31. PubMed ID: 10753223
[TBL] [Abstract][Full Text] [Related]
35. Mammary gland carcinogenesis by food-derived heterocyclic amines: metabolism and additional factors influencing carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Snyderwine EG
Environ Mol Mutagen; 2002; 39(2-3):165-70. PubMed ID: 11921185
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets.
Yao R; Wang Y; Lu Y; Lemon WJ; End DW; Grubbs CJ; Lubet RA; You M
Carcinogenesis; 2006 Jul; 27(7):1420-31. PubMed ID: 16403772
[TBL] [Abstract][Full Text] [Related]
37. Reduced Brca1 protein expression in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinomas.
Okochi E; Miyamoto K; Wakazono K; Shima H; Sugimura T; Ushijima T
Mol Carcinog; 2002 Aug; 34(4):211-8. PubMed ID: 12203372
[TBL] [Abstract][Full Text] [Related]
38. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats.
Hirose M; Yamaguchi T; Lin C; Kimoto N; Futakuchi M; Kono T; Nishibe S; Shirai T
Cancer Lett; 2000 Jul; 155(1):79-88. PubMed ID: 10814883
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Toyota M; Ushijima T; Weisburger JH; Hosoya Y; Canzian F; Rivenson A; Imai K; Sugimura T; Nagao M
Mol Carcinog; 1996 Mar; 15(3):176-82. PubMed ID: 8597530
[TBL] [Abstract][Full Text] [Related]
40. Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms.
Snyderwine EG
Cancer Lett; 1999 Sep; 143(2):211-5. PubMed ID: 10503906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
